MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis
Z. Stachowiak (Poznan, Poland), I. Wojsyk-Banaszak (Poznan, Poland), K. Jonczyk-Potoczna (Poznan, Poland), J. Gozdzik-Spychalska (Poznan, Poland), K. Sobczak (Poznan, Poland), B. Narozna (Poznan, Poland), A. Breborowicz (Poznan, Poland), A. Szczepankiewicz (Poznan, Poland)
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Stachowiak (Poznan, Poland), I. Wojsyk-Banaszak (Poznan, Poland), K. Jonczyk-Potoczna (Poznan, Poland), J. Gozdzik-Spychalska (Poznan, Poland), K. Sobczak (Poznan, Poland), B. Narozna (Poznan, Poland), A. Breborowicz (Poznan, Poland), A. Szczepankiewicz (Poznan, Poland). MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis. 2714
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Influence of salivary nitrite on levels in exhaled breath condensate in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Correlation of FE NO with nitrites and nitrates in exhaled breath condensate in cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
The role of galactomannan in exhaled breath condensate in detecting pulmonary aspergillosis in patients with exacerbated COPD Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012
Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008